MARKET

GNVR

GNVR

Genvor Inc
OTCMQB
0.850
NaN%
Closed 09:30 04/02 EDT
OPEN
--
PREV CLOSE
0.850
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.000
52 WEEK LOW
0.014
MARKET CAP
29.27M
P/E (TTM)
-21.0396
1D
5D
1M
3M
1Y
5Y
1D
Genvor CEO Chad Pawlak to Present at NIBA 152nd Investment Conference in Fort Lauderdale
Reuters · 03/05 13:05
Genvor Expands Into Consumer Health and Wellness Market
Reuters · 03/04 13:01
GENVOR ANNOUNCES STRATEGIC EXPANSION INTO HEALTH AND WELLNESS MARKET, LEVERAGING PROPRIETARY AI-ACCELERATED BIOCYPHER PLATFORM TO DEVELOP CONSUMER PEPTIDE SOLUTIONS
Reuters · 03/04 13:00
Genvor Inc. Appoints Dr. George Stavrides as Executive Vice President
Reuters · 01/28 13:05
GENVOR APPOINTS DR. GEORGE STAVRIDES AS EXECUTIVE VICE PRESIDENT, BUSINESS DEVELOPMENT & COMMERCIALIZATION
Reuters · 01/28 13:05
Genvor Inc. to Present AI-Accelerated Peptide Technology at DealFlow Discovery Conference
Reuters · 01/20 12:01
Genvor Inc. Files Initial Beneficial Ownership Statement; Dr. Jessee M. Jaynes Listed as Director and Chief Research Officer
Reuters · 12/05/2025 21:07
GENVOR AND TUSKEGEE UNIVERSITY ANNOUNCE TEAMING AGREEMENT TO ADVANCE PEPTIDE RESEARCH AND SUSTAINABLE CROP PROTECTION TECHNOLOGIES
Reuters · 12/02/2025 13:00
More
About GNVR
Genvor Incorporated is a developer of sustainable plant health solutions, with a portfolio of patented peptides to provide crops with anti-pathogen and enhanced nutritional properties through biological foliar application as well as transgenic seed traits. The Company’s proprietary BioCypher Algorithm combines computational biology, machine learning, and regulatory benchmarks to create peptides that optimize agricultural outcomes with biological safety. With multiple patents and proprietary peptides in active development, it offers ready-to-deploy licensing opportunities that integrate with existing production infrastructure and regulatory frameworks. The Company’s platform centers on the development of anti-microbial peptides (AMPs), which are designed to combat a broad spectrum of debilitating and destructive plant diseases including bacterial, fungal, and viral pathogens that threaten crop productivity worldwide.

Webull offers Genvor Inc stock information, including OTCMQB: GNVR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GNVR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GNVR stock methods without spending real money on the virtual paper trading platform.